Akèy › Timò Nèwo-endokrin › Massachusetts › Boston
Etid klinik pou Timò Nèwo-endokrin nan Boston, MA
5 etid pou Timò Nèwo-endokrin ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Ap rekriteFaz 2/3
- Dana-Farber Cancer Institute, Boston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Ap rekriteFaz 3
- Investigative Site, Boston
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
- Massachusetts General Hospital,, Boston
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Ap rekriteFaz 4
- Massachussets General Hospital, Boston
Etid Timò Nèwo-endokrin nan lòt vil
- Philadelphia, PA11 etid
- Washington, DC11 etid
- Rochester, MN9 etid
- Houston, TX8 etid
- Chicago, IL7 etid
- St. Louis, MO7 etid
- Columbus, OH7 etid
- Detroit, MI7 etid
- Salt Lake City, UT7 etid
- Cleveland, OH7 etid
- Dallas, TX6 etid
- Charlottesville, VA6 etid
Lòt etid nan Boston
- Kansè nan tete112 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)85 etid
- Kansè Metastatik63 etid
- Kansè kolorektal63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.